This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n12http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q37489324
rdf:type
wikibase:Item
schema:description
vedecký článok wissenschaftlicher Artikel scientific article published on September 2004 научни чланак مقالة علمية نشرت في سبتمبر 2004 vetenskaplig artikel artigo científico videnskabelig artikel wetenschappelijk artikel article scientifique bilimsel makale articolo scientifico article científic vědecký článek artículu científicu espublizáu en 2004 наукова стаття, опублікована у вересні 2004
p:P577
wds:Q37489324-2372D2AC-1D8D-4473-8A7E-D78B11AC717F
wdt:P577
2004-09-01T00:00:00Z
p:P407
wds:Q37489324-054ECE28-8FB3-483C-A92D-341C9E473046
wdt:P407
wd:Q1860
p:P2860
wds:Q37489324-367BA03E-6C6E-4954-A86D-ABB2E21BC5E9 wds:Q37489324-3AE2E406-5E58-4AE0-8E40-EFBDA870A11C wds:Q37489324-42622E99-756B-4685-BA21-65CEC509227B wds:Q37489324-530AFEE2-FF54-4361-90E3-7285DD1853CE wds:Q37489324-6AEEEF75-EF46-4312-9659-6FC0A9F9CFD2 wds:Q37489324-798848A7-ED53-432C-AA7A-F8C06BFF4718 wds:Q37489324-7CAC734C-F35A-408B-9358-DCFC71501AD7 wds:Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9 wds:Q37489324-90E48F3B-0A22-44C5-A562-DA1FCE18889F wds:Q37489324-9C591DBB-6769-4AF0-8AAF-96802CDCDA79 wds:Q37489324-9D029186-A1EB-4115-989C-0DFB3B72376F wds:Q37489324-A8768F9D-C9A7-438B-BA47-309A697EAF68 wds:Q37489324-B0DAA784-0BEC-4759-AF9C-452E3A35A9C0 wds:Q37489324-B2EFB2C5-511E-458B-90D6-1C85E1ADCE65 wds:Q37489324-D04CFD1F-241E-4088-B003-9A2DEA9F10CC wds:Q37489324-DC073A93-D922-42FB-BF1B-73B74F97298C wds:Q37489324-E04CE91E-DC29-462E-8F5C-70A12514C24A wds:Q37489324-0878D7F4-CF9B-4496-AD51-76D89293DF74 wds:Q37489324-1F545C0E-5CE0-4036-9FB7-9AD7EF37840E wds:Q37489324-24280047-8EA8-4616-B7A2-978D6726D2FF
wdt:P2860
wd:Q37868241 wd:Q41696128 wd:Q28271386 wd:Q28201389 wd:Q34505646 wd:Q43462235 wd:Q35630491 wd:Q34467495 wd:Q35548203 wd:Q34131200 wd:Q34994428 wd:Q44514665 wd:Q64130949 wd:Q44183645 wd:Q33975832 wd:Q43606797 wd:Q43608785 wd:Q75190399 wd:Q44690089 wd:Q74069252
p:P2093
wds:Q37489324-FA392375-F5D3-48B8-811B-C4EC234930E5 wds:Q37489324-4DBA53CC-805D-44D4-A051-B7CC3F4B3797 wds:Q37489324-3EB8635B-851A-40FD-8DE2-0E7FDE44B894 wds:Q37489324-746C1352-8C20-400C-B0AB-F816D0AC8331 wds:Q37489324-5EEC881B-7AAB-4AB1-9DBA-8365C51B1AC4
wdt:P2093
H Kurz 600 Study Group H Lode R Kozak H Xie
rdfs:label
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme
skos:prefLabel
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme
schema:name
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme
p:P50
wds:Q37489324-51A7153C-A670-471E-949F-2A76F3D544E7 wds:Q37489324-32570CFF-A79F-4B60-BD79-14C059C7DDE5
wdt:P50
wd:Q124419900 wd:Q63936952
p:P1476
wds:Q37489324-F41A53E0-B04F-42B6-944B-9EA7C75073E5
wdt:P1476
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults
p:P304
wds:Q37489324-6DC3CBC2-2FF6-484D-9BB7-7BAD1A6A3C6F
wdt:P304
3323-3331
p:P31
wds:Q37489324-D2EB0C40-64B2-45EB-96B6-17A8928AF0C7
wdt:P31
wd:Q13442814
p:P698
wds:Q37489324-5AB11F6C-0E49-4A11-AC56-4ECCDADE4B9F
wdtn:P698
n10:15328092
wdt:P698
15328092
p:P1433
wds:Q37489324-FC5CA762-AEFC-4C01-A573-8A695884C5BE
wdt:P1433
wd:Q578004
p:P433
wds:Q37489324-ED03BB54-3AC3-4487-8362-C1330E61FA7A
p:P478
wds:Q37489324-6CADD261-A9BC-4E76-BA64-1766D9283C3C
wdt:P433
9
wdt:P478
48
p:P356
wds:Q37489324-6C9CA91A-9D57-4CEA-AD23-5C65F7C2CBEA
wdtn:P356
n12:AAC.48.9.3323-3331.2004
wdt:P356
10.1128/AAC.48.9.3323-3331.2004
p:P932
wds:Q37489324-27057481-A359-45C7-A157-E0AB1D3A54D8
wdt:P932
514768